Additional Information
Short Description: |
Acetylcholinesterase inhibitor |
Research Area: |
Neuroscience, Neurodegeneration, Alzheimer's Disease, Cancer, Apoptosis |
Alternative Name(s): |
Galantamine hydrobromide, Galantamine HBr, Galanthamine hydrobromide, Galanthamine, Galanthamine hydrogen bromide, SPECTRUM1501202, 1,2,3,4,6,7,7a,11c-Octahydro-9-methoxy-2-methyl-benzofuro(4,3,2-efg)(2)benzazocin-6-ol HBr, LS-185021, Galanthamine, N |
Category: |
Small Molecules |
Product Type: |
Inhibitor |
CAS No.: |
1953-04-4 |
Molecular Formula: |
C17H22BrNO3 |
Molecular Weight: |
368,3 |
Source: |
Synthetic |
Purity: |
>97% (HPLC); NMR (Conforms) |
Solubility: |
Soluble in water (12 mg/ml) or in DMSO (10 mg/ml) |
Appearance: |
White powder |
Storage: |
-20ºC |
Shipping: |
Blue Ice or 4ºC |
SMILES: |
[Br-].COc1ccc2CN(C)CC[C@@]34C=C[C@H](O)C[C@@H]3Oc1c24.[H+] |
InChI: |
1S/C17H21NO3.BrH/c1-18-8-7-17-6-5-12(19)9-14(17)21-16-13(20-2)4-3-11(10-18)15(16)17;/h3-6,12,14,19H,7-10H2,1-2H3;1H/t12-,14-,17-;/m0./s1 |
InChIKey: |
QORVDGQLPPAFRS-XPSHAMGMSA-N |
Field of Use: |
For in vitro research use only. |
Related Products
Galanthamine hydrobromide | E1KS1339
426
NULL405.00
Galanthamine hydrobromide | E1KS1339 | Gentaur UK, US & Europe Distribution
426-E1KS1339
